Category: Sectors

Categories
Technology Stocks

Sabre Files for Potential Equity Offerings; Shares Cheap

20025825 - closeup image of businessman drawing 3d graphics

sending shares down 8%. In our view, Sabre has enough liquidity in a zero-demand environment for around a year, and probably at least two years at second-quarter 2021 demand levels. This stance is buoyed by Sabre last communicating a monthly cash burn figure of $80 million in a zero-demand environment during its earnings call on 6th Nov 2020. Since then, management said on its Feb. 16, 2021, earnings call that it expected cash burn to improve throughout 2021. On the Aug. 3, 2021, call management said cash burn improved sequentially and that Sabre had $1.1 billion in cash on the balance sheet, with no debt maturing until 2024 and no significant uses for cash in the near term. 

Sabre expects to reach free cash flow break-even levels when its air volumes reach 56%-67% of 2019 levels. Sabre’s total air bookings recovered to 51% of 2019 levels in June, up from 38% in May and 24% in its first quarter. U.S. hotel industry revenue per available room has not weakened through mid-August, and even during 2020 case surges U.S. travel demand only paused for a few weeks before continuing an improving trend, illuminating the desire to travel. Still, after holding at around 80% of 2019 levels through mid-August, U.S. air volumes have averaged around 74% for days 16-19 of the month.

And importantly for Sabre, it is a later cycle recovery play tied to corporate travel improving, which is being delayed by pushouts of return to office. We are monitoring any potential impact to demand from the delta variant of the coronavirus. We currently estimate that Sabre’s second-half 2021 air bookings will reach 54% of 2019 levels, a small improvement from June levels. While share price action may remain volatile, we still see investors greatly discounting Sabre’s narrow moat, with shares trading well below our $16.20 fair value estimate.

Company Profile 

Sabre holds the number-two share of global distribution system air bookings (40.9% as of the end of 2020 versus 38.8% in 2019). The travel solutions segment represented 88% of total 2020 revenue, which was split evenly between distribution and airline IT solutions revenue. The company also has a growing hotel IT solutions division (12% of revenue). Transaction fees, which are tied to volume and not price, account for the bulk of revenue and profits.

(Source: Morningstar)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Shares Technology Stocks

Palo Alto’s Product Demand Accelerates in Q4 As Next-Gen Security Soars

Male gamer in headphones holds joystick and playing videogame on console or desktop PC, gaming lifestyle, cybersport. Computer games player in his room with neon light, streamer

its next-generation firewall appliance altering the requirements of this essential piece of networking security. The firm’s portfolio has expanded outside of network security into areas such as cloud protection and automated response. The complexity of an entity’s threat management increases as the quantity of data and traffic being generated off-premises grows. Security point solutions were traditionally purchased to combat the latest threats, and IT teams had to manage various vendors’ products simultaneously, which leads us to believe that IT teams are clamoring for security consolidation to manage disparate solutions. Core to Palo Alto’s technology is its security operating platform, which provides centralized security management. Palo Alto’s concerted efforts into machine learning, analytics, and automated responses could make its products indispensable within customer networks.

Financial Strength 

Palo Alto ended fiscal 2021 with $2.9 billion in cash and cash equivalents and total debt of $3.2 billion in 2023 and 2025 convertible senior notes. The $1.7 billion 2023 notes mature in June 2023 and have a 0.75% fixed interest rate per year paid semiannually, while the $2.0 billion of notes that mature June 2025 have a 0.375% interest rate paid semiannually. The company announced a $1.0 billion share-repurchase authorization in February 2019, which was increased to $1.7 billion the following year with an expiration at the end of 2021, and has subsequently extended the program.

Our fair value estimate for narrow-moat Palo Alto Networks to $440 per share from $400 after its fourth quarter earnings bolstered our confidence in its long-term opportunity within the cybersecurity market. Shares are modestly undervalued, in our view, even after jumping more than 10% following the strong results in the fourth quarter. Palo Alto breezed by our lofty expectations, and previous guidance, for the fourth quarter, with 28% year-over-year revenue growth and adjusted earnings of $1.60. Billings grew by 34% year over year, and remaining performance obligations, or RPO, increased by 36% year over year to $5.9 billion. 

Subscriptions and support increased by more than 36% while product revenue accelerated to 11% growth, both year over year. Its core firewall offerings continue to outpace the market, with 26% year-over-year billings growth and software-based versions represented 47% of firewall billings in the quarter. Next-gen security billings increased by 71% year over year, and now represent 33% of total billings, as the demand for cloud security and automation ramps up in the industry. Next-gen ARR increased by 81% year over year to $1.2 billion. 

Bulls Say’s 

  • Adding on modules to Palo Alto’s security platform could win greenfield opportunities and increase spending from existing customers.
  • Palo Alto could showcase great operating margin leverage as it moves from brand creation into a perennial cybersecurity leader. Winning bids should be less costly as the incumbent, and we think Palo Alto is typically on the short list of potential vendors.
  • The company is segueing into high-growth areas to supplement its firewall leadership. Analytics and machine learning capabilities could separate Palo Alto’s offerings.

Company Profile 

Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company’s product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.

(Source: Morningstar)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Global stocks Shares

SYD’s share price up by 41.5% over the past year

Investment Thesis:

  • Currently share price is supported by recent takeover offers which have been rejected.
  • Earnings affected by the pandemic; Attractive asset with long-dated lease – Sydney International Airport.
  • Long-term growth is anticipated in international and domestic travel.
  • Solid and high growing dividend stream was offered by SYD before Covid, which is expected to repeat post Covid recovery.
  • Development of new projects (expansion of capacity & improvement of passenger experience). 
  • Leveraged due to a falling dollar (cheaper to visit Australia). 
  • Diversification into hotels for earnings.
  • New markets to drive business growth e.g. India, new emerging markets

Key Risks:

  • Bond rates (which is seen as a bond proxy and rising bonds yields would negatively affect SYD’s valuation) 
  • Slowdown in Australian travel and tourism. 
  • Universal calamity which might lead to downsizing of international travel.
  • Disappointment created by growth distribution and its absence.  
  • Disruptions caused due to cost pressure and operations.
  • Less exposure to Australia by International Airlines. 
  • Long-term competition majorly from Western Sydney Airport. 

Key Highlights:

  • SYD’s share price is $7.70 (+41.5% in comparison to past year); however cannot surpass the price which was at the beginning of pandemic i.e. $8.41.
  • Revenue of $341.6m indicated a sharp decline of -33.2%. The decrease in the rate of passengers of SYD was -36.4%.
  • SYD retained a financially healthy balance sheet with $2.9bn of liquidity as at 30 June.
  • EBITDA of $210.8m was down by -29.8%.
  • Revenue of Aeronautical constitutes 36% amounting to $110.82m, declined -36% or -27.0% on an adjusted basis on lower passenger volumes, down -36.4%.
  • Revenue of Retail (28% of the total revenue) amounts to $87.4m (or $27.5m when adjusted for rental abatements and doubtful debts) declined -40.6% (or -73.4% on an adjusted basis). 
  • Revenue of Property and car rental (27% revenue by segment) of $84.6m (or $83.5m when adjusted for rental abatements and doubtful debts), was down -22.3% (or up +1.1% on an adjusted basis).
  • Revenue of Car parking and ground transport consists of 9% amounting to $28.7m (or $27.8m when adjusted for rental abatements and doubtful debts), which was down -24.7%.

Company Profile:

Sydney Airport Holdings is a publicly–listed Australian holding company which owns a 100% interest in Kingsford Smith Airport via Sydney Airport Corporation. The company is listed on the Australian Stock Exchange and has its head office located in Sydney, New South Wales. The principal activity of the Company is investment in airport assets. The Company’s investment policy is to invest funds in accordance with the provisions of the governing documents of the individual entities within the Company. The Company consists of Sydney Airport Limited (SAL) and Sydney Airport Trust 1 (SAT1). The Trust Company (Sydney Airport) Limited (TCSAL) is the responsible entity of SAT1.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Shares Small Cap

Inghams delivered a strong result in spite of national lockdowns in Australia and NZ

Investment Thesis 

  • The pricing condition is improving.
  • The largest integrated poultry producer in Australia and New Zealand.
  • Additional asset sales are planned.
  • Project Accelerate has proven to be effective in increasing labor productivity and automation, resulting in increased earnings despite lower revenue.
  • Procurement measures are being executed, and the results are meeting expectations.
  • Investing in Australia and New Zealand plants to boost capacity and capabilities across the board.
  • With a healthy balance sheet, capital management measures are high on the agenda.

Key Risks

  • Re-negotiation of important contracts with significant clients on less favourable terms.
  • Increased feed and electricity costs, which could be passed on to customers through market price hikes, lowering competitiveness.
  • Uncertainty arises from the lack of information on the appointment of a new CEO.
  • In QSRs (Quick Service Restaurants) and supermarkets, there is a risk of customer concentration.
  • Exotic disease outbreaks are a risk, limiting ING’s ability to produce poultry goods.
  • From the parent stock provider, there has been a significant decline in volume and quality.
  • Material disruptions in ING’s intricate and interconnected supply chain.

Key FY21 group results 

Despite the impact of Covid-19, ING delivered solid FY21 results that were in line with management’s recent guidance (EBITDA & NPAT) issued on May-21. In comparison to the previous year, group revenue increased by +4.4 percent (with Core Poultry volumes increasing by +4.2 percent, with volume growth in NZ exceedingly strong at +6.3 percent), underlying EBITDA increased by +9.6 percent, and underlying NPAT increased by +57.4 percent. Coverage expansion in wholesale and recovery in the QSR and food service channels drove top-line growth. Total dividends increased +17.9 percent year on year to 16.5cps, representing a payout ratio of 71 percent after earnings growth (in line with policy targets of 60 – 80 percent of underlying NPAT post AASB 16 adjustments). The balance sheet is in excellent shape, with net debt falling by -23.7 percent to $240.2 million in the last year. Group leverage fell from 1.8x to 1.2x, well within management’s 1.0–2.0x target range.

Company Description  

Inghams Group Ltd (ING) is Australia and New Zealand’s largest integrated poultry producer. The Company produces and sells chicken, turkey and stock feed that are used by the poultry, pig, dairy and equine industries. Over one quarantine facility, over ten feed mills, over 74 breeder farms, over 11 hatcheries, over 225 predominantly contracted broiler farms, over seven primary processing plants, over seven further processing plants, over one protein conversion plant, and over nine distribution centres are among the Company’s operations in Australia and New Zealand. Ingham’s and Waitoa are two of the company’s brands.

Source: (BanayanTree)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Technology Stocks

Maintaining BioNTech FVEs after Comirnaty Approval

received full approval from the U.S. Food and Drug Administration on Aug. 23 for individuals age 16 and older. Pfizer and BioNTech fair value estimates are maintained. The mRNA technology that formed the basis of the vaccine provides support to Pfizer’s established wide moat and also contributes to BioNTech’s positive moat trend.

Government contracts for the initial two-dose series and established contracts are more than sufficient to cover any increased demand. The demand for these purchased vaccines could increase with full approval, which could help to end the most recent surge driven by the delta variant. This could encourage some individuals who were uncertain about the long-term safety of the vaccine to get vaccinated. 

In the U.S., roughly 60% of the vaccine-eligible population has been fully vaccinated. President Joe Biden’s target for a return to near normal by July 4 was thwarted by a combination of vaccine hesitancy, waning efficacy of vaccines, and the rise of the more contagious delta variant. Herd immunity could still be achievable, but the delta variant raises the bar; it therefore could depend on new mandates or increased willingness to vaccinate following Pfizer’s Aug. 23 full approval, uptake of third-dose booster shots, and the potential rise of vaccine-resistant variants down the line. 

Company’s Future Outlook

It continues to see sales reaching $35 billion in 2021 and $39 billion in 2022, followed by roughly $2 billion in annual sales beyond 2022 as it is expected post pandemic annual COVID vaccines for only the most vulnerable (infants and seniors). It is expected this approval to give more leverage to public and private organizations wishing to mandate vaccination, including universities and hospitals.

Full approval also makes it easier for doctors to prescribe off-label use of the vaccine, which could provide more flexibility with the timing of booster shots. Most physicians are waiting for a nod from the Centers for Disease Control’s Advisory Committee on Immunization Practices, which could come next week, before recommending booster shots beyond immunocompromised individuals.

Company Profile

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company’s oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.

(Source: Morningstar)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Dividend Stocks

ASX performed a mixed FY21 as a result of retail trading

Investment Thesis

  • M&A that adds value or product/service innovation
  • Monopoly position in a number of segments, with an EBIT margin of 70% and ROTE of 30%.
  • A quality management team has been established to assist any new CEO. The team has a detailed awareness of future operational and IT requirements, as well as strong ties to legislators and regulators.
  • With net cash and an AA credit rating, the balance sheet is strong.
  • The ASX stands to profit from rising superannuation and population trends.
  • The ASX could profit from global connectivity’s fundamental expansion.

Key Risks

  • Capex execution runs the risk of falling short of expectations in terms of ROIC.
  • Volume growth is expected to be slow, while profitability are expected to be flat.
  • Competitors’ or a new start-technological up’s and product innovation could jeopardise ASX’s market hegemony.
  • Regulation poses a threat.

FY21 results summary

Operating revenue increased +1.4 percent year on year to $951.5 million, driven by strong growth in Listings& Issuer Services (supported by new listings and increased issuer activity), Equity Post-Trade Services (reflecting higher settlement activity), and Trading Services (underpinned by increased demand for information services), partially offset by declines in Derivatives and OTC Markets as current policy settings reverted. Total expenses increased by +8.4 percent years on year to $310.3 million, in line with management’s guidance of +8-9 percent growth, due to additional costs to support licence to operate and growth initiatives, as well as variable costs associated with issuer activity. EBIT fell -1.7 percent years on year, with margin falling -210 basis points to 67.4 percent. Statutory profit was -3.6 percent lower than pcp. Net interest income fell 44.3 percent year on year to $46.7 million as a result of the RBA’s current policy settings, which resulted in lower interest earnings on ASX’s own capital and a lower investment spread on ASX collateral. Capital expenditure (capex) was $109.8 million, up 36.5 percent year on year, reflecting the expanded CHESS replacement project and ASX’s ongoing commitment to strengthen foundations for a future exchange.

Company Description  

ASX Ltd (ASX) operates Australia’s main stock exchange and equity derivatives market. ASX has four core segments:  (1) Listings and Issuer Services (covers capital raisings, investment products, and a range of services ASX provide to listed companies); (2) Derivatives and OTC Markets (covers OTC Clearing, equity options and Austraclear including the ASX collateral management service); (3) Trading Services (encompasses cash equities trading, information services and technical services); and (4) Equity Post-Trade Services (encompasses the clearing and settlement of the entire Australian cash market).

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Global stocks Shares

Analysts estimate increase in Stifel Fair Value

Additionally, an initial need for capital in the recession and then low interest rates and a strong stock market led to high capital-raising activity.

Stifel Financial has a long history of being an active acquirer. With several hundred million dollars of arguably excess capital, the company could make some decent-size acquisitions. The company may see some growth from a renewed commitment to its independent advisor business.

Stifel has been deepening its expertise in certain niche areas lately through acquisitions. The KBW merger improved the company’s presence in financial industry investment banking, and Stifel has made a series of public finance firm acquisitions over the past several years. In wealth management, adding Barclays’ advisors can help the firm move more upmarket. The investment banking and wealth management landscape is undergoing a decent amount of change from regulations, such as those related to capital requirements and fiduciary standards.

Financial Strength:

Stifel’s financial health is fairly good. At the end of 2020, the company had approximately $1.1 billion of corporate debt and over $2 billion of cash on its balance sheet. Its next large debt maturity is $500 million in 2024.The Company’s total leverage is less than 8, which is fair considering the mix of its investment banking and traditional banking operations. At the end of 2020, Stifel was at its disclosed target of 11.9% Tier 1 leverage ratio. Given that its Tier 1 leverage ratio is above management’s previously stated target of 10%, the company would resume more material share repurchases or pursue acquisitions. 

Bulls Say:

Stifel’s string of acquisitions has increased operational scale and expertise. Stifel is an experienced acquirer and integrator. A recession could provide ample acquisition opportunities. Net interest income growth over the previous several years at the company’s bank materially expanded wealth management operating margins, and the increased size of the bank and wealth management business provides diversification with its institutional securities business.

Company Profile:

Stifel Financial is a middle-market-focused investment bank that produces more than 90% of its revenue in the United States. Approximately 60% of the company’s net revenue is derived from its global wealth management division, which supports over 2,000 financial advisors, with the remainder coming from its institutional securities business. Stifel has a history of being an active acquirer of other financial service firms.

(Source: Morningstar)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Global stocks

G8 Education Fair Value Cut to AUD 2.00 but Remains Materially Undervalued

Although the result contained several positive aspects, we now expect some of G8’s recent expenses growth to be permanent. This expectation results in a reduction in our long-term profit margin expectations, with our long-term underlying NPAT margin forecast falling to 12% from 14%.

The market reacted negatively to G8’s result, with the share price falling 6% on the day. G8 usually generates most of its revenue in the second half of the year which typically boosts profit margins. However, the company has been unable to increase prices as usual in the middle of this year, due to the pandemic, which will impact margins in the second half. G8’s prices have been unable to keep pace with wages growth over the past couple of years, partly due to lower immigration due to the pandemic. Although management have created strategies to address the scarcity of labour and labour productivity, these solutions have costs too. G8’s earnings are particularly sensitive to wage inflation because wages typically equate to around 60% of revenue and because G8’s margins are relatively small.

G8’s management said that attracting and retaining talent is the greatest challenge facing the sector. In July 2021, G8’s occupancy rate had recovered to just 1 percentage point below levels achieved in July 2019, before the pandemic. However, the coronavirus outbreak and related lockdowns have caused this gap to widen to 2.6 percentage points in August 2021, relative to August 2019. We expect the second half of 2020 will be tough for G8, with lockdowns likely to continue for most of the half. However, we also expect Australian vaccination rates to enter 2022 with 70% to 80% of the population likely vaccinated, paving the way for a permanent reopening of the country.

Although the latest childcare sector support measures are a positive for childcare centre operators, they only add to the complexity of forecasting G8’s near-term earnings. Aside from the complexity caused by the pandemic’s impact on occupancy rates and subsidies, G8’s earnings are also distorted by recent reshuffling of its childcare centre portfolio, re -categorisation of expenses, the ramp-up of new centres, and change to the definitions of key performance indicators, such as occupancy. This complexity may mean the market will remain wary of G8 shares until the expected recovery is evidenced in reported results, likely in late 2022.

Despite our lower fair value, at the current market price of AUD 0.99 per share, we continue to believe G8 is materially undervalued. Although the childcare industry faces turmoil in the near term and wage inflation pressures in the longer term, we still expect G8’s occupancy rates to recover in 2022 as the pandemic subsides. Importantly, G8’s decision to raise equity capital in 2020, and repay all its net debt, means the company is well placed to weather the latest lockdowns and will likely reinstate dividends in 2022. The reinstatement of G8’s dividends will be an important step for Australian tax residents, because they will likely be fully franked. Franked dividends are effectively a return of corporate tax to shareholders and the reinstatement of franked dividends, which we expect in early 2021, may be a catalyst for a rerating of the stock.

Company Profile

G8 Education operates a portfolio of around 480 childcare centres in Australia, implying a market share of around 8%. The company is highly dependent on government subsidies, which comprise around 60% of childcare fees, but we expect subsidies to continue growing with childcare demand. G8 does not own the buildings from which its childcare centres operate, and labour costs comprise around 60% of expenses, with rental costs comprising around 15%.

(Source: Morningstar)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Global stocks Shares

Positive effect on Amcor stock as the company’s net income and free cash flow increase

  • Flattering exposure to the growth of both emerging and developed markets.
  • A well-defined strategy for increasing shareholder value.
  • Acquisitions that are bolt-ons provide an opportunity to supplement organic growth.
  • A strong balance sheet.
  • Leveraged against a falling AUD/USD
  • Advantages from the recently finished Bemis acquisition will begin to flow.
  • Capital management initiatives include a $500 million share buyback currently underway.

Key Risks

The following are the key challenges to the investment thesis:

  • Management fails to realise the proposed synergies in the Bemis transaction.
  • Increasing competition causing margin erosion and potential balance-sheet stress (e.g. reduced earnings leading to potential debt covenant breaches).
  • Cost constraints on inputs that the company is unable to pass on to customers (even though the Company does pass through input costs).
  • Global economic growth has slowed.
  • Value-destroying acquisition.
  • The risk of emerging markets.
  • Unfavorable movements in the AUD/USD.

Highlights of key FY21 results

  • EBIT increased by 8% to $1,621 million, with margins enhancing by +60 basis points to 12.6 percent. 
  • GAAP net income of $939 million, a +53 percent increase, translates to GAAP EPS of 60.2 cents, a +58 percent increase (or adjusted EPS of 74.4 cents, a +16 percent increase on a CC basis, above guidance range).
  • Adjusted FCF of $1.1bn, flat -9.9 percent over pcp (albeit at the upper end of guidance range), effected by rising capex on organic growth projects, lower working capital benefit, and adverse tax payment timing compared to pcp.
  • Return on average funds employed of 15.4 percent, an increase of +140 basis points over the pcp. 
  • The Board declared a final dividend of 11.75 cents per share, bringing the full-year dividend to 47 cents per share, and repurchased $350 million (2% ) of outstanding shares.

Company Description 

Amcor Limited (AMC) is an international integrated packaging company offering packing and related services. Amcor primarily produces a wide range of packaging products which include corrugated boxes, cartons, aluminum and steel cans, flexible plastic packaging, PET plastic bottles and jars, and multi-wall sacks. The company has operations in Australasia, North America, Latin America, Europe and Asia.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Dividend Stocks

P&G Cleans Up in Fiscal 2021, but Inflationary and Competive Headwinds Could Stall Its Trajectory

                   

 However, this performance is not solely a by-product of the pandemic, which has seen consumers place an outsize emphasis on cleaning and disinfecting. Rather, we attribute these marks to the strategic course P&G embarked on more than seven years ago (rightsizing its category and geographic reach by shedding more than 100 brands to ensure resources were being effectively allocated to the highest-return opportunities, while maintaining a stringent focus on costs). As a part of this playbook, P&G also adopted a more holistic approach to brand investing across its business .

But even as its top line appears healthy, P&G is facing unrelenting commodity cost inflation that management has qualitatively pegged as some of the most significant in some time. However, we think the degree of inflation combined with P&G’s innovation mandate (rooted in consumer-valued new fare) should make such increases more palatable. Further,  P&G is now involved in leaning into brand spending to illustrate the value its products offer consumers as opposed to turning off the spigot to preserve profits in this uncertain climate. This aligns with our forecast for P&G to direct around 3% and 10%-11% of sales long term to research and development and marketing, respectively, relative to the 2.7% and 10.5% expended on average the past five years.

Financial Strength

P&G maintains solid financial health. The firm continues to throw off a significant amount of cash, with free cash flow amounting to around $15 billion in fiscal 2021 .We expect P&G will remain committed to returning excess cash to shareholders and will increase its dividend, to an average payout ratio north of 60%. For the year 2020 the firms revenue stood at 70.950 USD million while its EBIT was 16,143 USD million. On the other hand the firms EV/EBIDTA was 18.2 while its P/E ratio was 23.4 for the year 2020.

 We believe P&G is also open to bolting on select brands and businesses to its mix over time. The firms acquired Germany-based narrow-moat Merck’s consumer healthcare brands for $4 billion in April 2018. In our view, this deal stood to replace the scale and technological know-how lost following the dissolution of its joint venture partnership with no-moat Teva at the end of fiscal 2018. As such, we don’t think it signals a reversal in the firm’s strategy to operate with a leaner brand mix. Rather, at just 1%-2% of sales, we believe this addition aligned with management’s rhetoric that it intends to selectively bolster its reach in attractive categories (consumer health growing midsingle digits) and geographies. Beyond this deal, P&G has failed to assert itself as a consolidator in the global household and personal-care arena.

Bulls Say

  • To the extent that retailers and consumers continue to find favour with leading branded operators, P&G’s sales trajectory may outpace our expectations.
  • Additional opportunities to narrow its product mix could enable P&G to more effectively direct its brand spending to the highest-return areas.
  • As P&G reaches the end of its second $10 billion cost reduction effort, further savings (probably related to reducing overhead and bolstering the yield on its manufacturing footprint and marketing investments) could manifest if efficiency is as engrained in its culture as management suggests.

Company Profile

Since its founding in 1837, Procter & Gamble has become one of the world’s largest consumer product manufacturers, generating more than $75 billion in annual sales. It operates with a line up of leading brands, including 21 that generate more than $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. P&G sold its last remaining food brand, Pringles, to Kellogg in calendar 2012. Sales outside its home turf represent around 55% of the firm’s consolidated total, with around one third coming from emerging markets.

(Source: Morningstar)

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.